Cervical Cancer Screening and Management: What's New in Clinical Guidelines-Recorded Webinar

Video Transcription

Video Summary

In this webinar, Dr. Dianne Davey provided an update on cervical cancer screening and the latest clinical guidelines. As a professor of pathology with extensive expertise and numerous accolades, Dr. Davey discussed the historical context and current challenges in cervical cancer screening. She outlined the transition towards human papillomavirus (HPV) primary screening, highlighting its higher sensitivity and negative predictive value compared to cytology. The American Cancer Society has begun advocating for HPV primary screening starting at age 25, citing improved early detection. Dr. Davey explained the clinical management guidelines for cervical cancer which are now more personalized and risk-based, depending on immediate CIN3 risk percentages that guide decisions between routine surveillance and further procedures like colposcopy or treatment. She underscored the importance of using FDA-approved HPV platforms for primary screening and noted the potential challenges related to HPV negative high-grade lesions and disparities in patient follow-up. Furthermore, the app and web-based tools provided by the American Society for Colposcopy and Cervical Pathology assist clinicians in making informed management decisions, tailored specifically to patient histories and test results. Dr. Davey addressed concerns about training medical residents in Pap test interpretations amidst shifting screening methods, emphasizing the value of cytology in cytologic-histologic correlation and clinical decision-making. The session concluded with Q&amp;A, where Dr. Davey expanded on the application of these guidelines in practice and the potential role of self-sampling in increasing screening accessibility.

Keywords

cervical cancer screening

HPV primary screening

clinical guidelines

Dr. Dianne Davey

American Cancer Society

personalized risk-based management

FDA-approved HPV platforms

cytology

self-sampling

screening accessibility